The pathogenesis of congenital cardiovascular anomalies.
D000014:Abnormalities, Drug-Induced; D000818:Animals; D001391:Azo Compounds / Q000009:adverse effects; D004626:Embryology; D005260:Female; D006321:Heart / Q000196:embryology; D006330:Heart Defects, Congenital / Q000139:chemically induced / Q000209:etiology*; D006801:Humans; D000860:Hypoxia / Q000150:complications; D011247:Pregnancy; D011248:Pregnancy Complications; D011251:Pregnancy Complications, Infectious; D051381:Rats; D012409:Rubella / Q000150:complications; D013792:Thalidomide / Q000009:adverse effects; D014343:Trypan Blue / Q000009:adverse effects; D014777:Virus Diseases / Q000150:complications
D001391:Azo Compounds; D013792:Thalidomide; D014343:Trypan Blue